UK markets closed

Polarean Imaging Plc (POLX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
3.7500-0.0500 (-1.32%)
At close: 03:49PM BST

Polarean Imaging Plc

2500 Meridian Pkwy
#175
Durham, NC 27713
United States
919 206 7900
https://polarean.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees28

Key executives

NameTitlePayExercisedYear born
Mr. Kenneth Paul WestChairman of the Board45.37kN/A1957
Dr. Bastiaan Driehuys Ph.D.Founder, Chief Scientific Officer & Director29.18kN/A1970
Mr. Charles Fremont Osborne Jr.CFO & Director273.52kN/A1966
Dr. Christopher Richard Von Jako Ph.D.CEO & DirectorN/AN/A1970
Mr. Neil WadehraVice President of OperationsN/AN/A1980
Mr. Alex DusekChief Commercial OfficerN/AN/A1967
Mr. Stephen AustinCompany SecretaryN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. Its research equipment includes HPX hyperpolarizer, HPX measurement station, HPX gas manifold, chest coil, and dose delivery bags. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.

Corporate governance

Polarean Imaging Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.